UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)

Molecular genetics and metabolism, 2019-11, Vol.128 (3), p.213-218

2019

Volltextzugriff (PDF)

ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

The American journal of gastroenterology, 2014-07, Vol.109 (7), p.950-966

2014

Volltextzugriff (PDF)

Recent insights into the biological functions of liver fatty acid binding protein 1

Journal of lipid research, 2015-12, Vol.56 (12), p.2238-2247

2015

Volltextzugriff (PDF)

Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria

The New England journal of medicine, 2019-02, Vol.380 (6), p.549-558

2019

Volltextzugriff (PDF)

Acute hepatic porphyrias: Recommendations for evaluation and long‐term management

Hepatology (Baltimore, Md.), 2017-10, Vol.66 (4), p.1314-1322

2017

Volltextzugriff (PDF)

Acute Porphyrias in the USA: Features of 108 Subjects from Porphyrias Consortium

The American journal of medicine, 2014-12, Vol.127 (12), p.1233-1241

2014

Volltextzugriff (PDF)

Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review

World journal of gastroenterology : WJG, 2016-08, Vol.22 (29), p.6742-6756

2016

Volltextzugriff (PDF)

Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network

Hepatology (Baltimore, Md.), 2014-10, Vol.60 (4), p.1399-1408

2014

Volltextzugriff (PDF)

Spectrum of statin hepatotoxicity: Experience of the drug‐induced liver injury network

Hepatology (Baltimore, Md.), 2014-08, Vol.60 (2), p.679-686

2014

Volltextzugriff (PDF)

Herbal Products and the Liver: A Review of Adverse Effects and Mechanisms

Gastroenterology (New York, N.Y. 1943), 2015-03, Vol.148 (3), p.517-532.e3

2015

Volltextzugriff (PDF)

Hepatic histological findings in suspected drug‐induced liver injury: Systematic evaluation and clinical associations

Hepatology (Baltimore, Md.), 2014-02, Vol.59 (2), p.661-670

2014

Volltextzugriff (PDF)

MicroRNA‐196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins

Hepatology (Baltimore, Md.), 2010-05, Vol.51 (5), p.1494-1504

2010

Volltextzugriff (PDF)

Acute Hepatic Porphyrias: Review and Recent Progress

Hepatology communications, 2019-02, Vol.3 (2), p.193-206

2019

Volltextzugriff (PDF)

BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma

Cancer letters, 2017-12, Vol.411, p.117-129

2017

Volltextzugriff (PDF)

Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements

Hepatology (Baltimore, Md.), 2017-04, Vol.65 (4), p.1267-1277

2017

Volltextzugriff (PDF)

HLA‐B35:01 and Green Tea–Induced Liver Injury

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2484-2493

2021

Volltextzugriff (PDF)

miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling

PloS one, 2018-07, Vol.13 (7), p.e0200847-e0200847

2018

Volltextzugriff (PDF)

Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyrias

Frontiers in pharmacology, 2022-09, Vol.13, p.953961-953961

2022

Volltextzugriff (PDF)

Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction

Molecular genetics and metabolism, 2019-11, Vol.128 (3), p.242-253

2019

Volltextzugriff (PDF)

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study

Liver international, 2022-01, Vol.42 (1), p.161-172

2022

Volltextzugriff (PDF)

Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate

Circulation research, 2008-03, Vol.102 (6), p.669-676

2008

Volltextzugriff (PDF)

Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group

PloS one, 2018-10, Vol.13 (10), p.e0206389-e0206389

2018

Volltextzugriff (PDF)

Clinically important features of porphyrin and heme metabolism and the porphyrias

Metabolites, 2014-11, Vol.4 (4), p.977-1006

2014

Volltextzugriff (PDF)

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Gastroenterology (New York, N.Y. 1943), 2009-01, Vol.136 (1), p.138-148

2009

Volltextzugriff (PDF)

Hepatitis C, porphyria cutanea tarda and liver iron: an update

Liver international, 2012-07, Vol.32 (6), p.880-893

2012

Volltextzugriff (PDF)

1 – 25 von 481

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(446)
Mit Volltextzugriff
(401)

Publikationsform

Sprache

Englisch
(480)
Deutsch
(1)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(315)
Life Sciences & Biomedicine
(306)
Humans
(259)
Gastroenterology & Hepatology
(161)
Male
(143)
Female
(128)
Middle Aged
(116)
Biological And Medical Sciences
(112)
Medical Sciences
(100)
Adult
(92)
Animals
(68)
Liver
(47)
Aged
(46)
Infectious Diseases
(46)
Hepatitis C, Chronic - Drug Therapy
(44)
Human Viral Diseases
(43)
Viral Diseases
(43)
Viral Hepatitis
(43)
Gastroenterology. Liver. Pancreas. Abdomen
(42)
Gastroenterology And Hepatology
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)

ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

Recent insights into the biological functions of liver fatty acid binding protein 1

Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria

Acute hepatic porphyrias: Recommendations for evaluation and long‐term management

Acute Porphyrias in the USA: Features of 108 Subjects from Porphyrias Consortium

Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review

Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network

Spectrum of statin hepatotoxicity: Experience of the drug‐induced liver injury network

Herbal Products and the Liver: A Review of Adverse Effects and Mechanisms

Hepatic histological findings in suspected drug‐induced liver injury: Systematic evaluation and clinical associations

MicroRNA‐196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins

Acute Hepatic Porphyrias: Review and Recent Progress

BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma

Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements

HLA‐B35:01 and Green Tea–Induced Liver Injury

miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling

Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyrias

Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study

Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate

Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group

Clinically important features of porphyrin and heme metabolism and the porphyrias

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

Hepatitis C, porphyria cutanea tarda and liver iron: an update

Suchergebnisse filtern